Lisa B Thorell1, Kerstin Dahlström. 1. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Lisa.Thorell@psyk.uu.se
Abstract
OBJECTIVE: This study investigates children's views on positive and negative effects of stimulant medication for ADHD and the children's willingness to stop taking medication. METHOD: Questionnaire data were collected from 79 children with ADHD and one of each child's parents. RESULTS/ CONCLUSION: Swedish children treated with stimulants generally experienced positive treatment effects in many areas, especially in the school setting, and a majority wished to continue taking their medication. There was, however, a small group of children who reported a relatively large number of negative effects. Few differences between parents and children were found for positive effects, although parents reported higher levels of negative effects. Results also indicate that the child's knowledge of why he or she is on stimulant medication and the parent's views of medication are important factors to take into consideration as they influence the child's willingness to continue his or her medication.
OBJECTIVE: This study investigates children's views on positive and negative effects of stimulant medication for ADHD and the children's willingness to stop taking medication. METHOD: Questionnaire data were collected from 79 children with ADHD and one of each child's parents. RESULTS/ CONCLUSION: Swedish children treated with stimulants generally experienced positive treatment effects in many areas, especially in the school setting, and a majority wished to continue taking their medication. There was, however, a small group of children who reported a relatively large number of negative effects. Few differences between parents and children were found for positive effects, although parents reported higher levels of negative effects. Results also indicate that the child's knowledge of why he or she is on stimulant medication and the parent's views of medication are important factors to take into consideration as they influence the child's willingness to continue his or her medication.
Authors: Greta A Bushnell; M Alan Brookhart; Bradley N Gaynes; Scott N Compton; Stacie B Dusetzina; Til Stürmer Journal: Med Care Date: 2018-06 Impact factor: 2.983
Authors: Kevin M Antshel; Teresa M Hargrave; Mihai Simonescu; Prashant Kaul; Kaitlin Hendricks; Stephen V Faraone Journal: BMC Med Date: 2011-06-10 Impact factor: 8.775
Authors: Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud Journal: Cochrane Database Syst Rev Date: 2018-05-09